This week’s mass tort settlement news brought major movement across four federal dockets. Pfizer agreed to resolve the Depo-Provera brain tumor litigation. The Supreme Court is poised to rule on Roundup. Meanwhile, a paraquat judge tightened pressure on settlement holdouts. In addition, a new baby formula trial was ordered after a defense verdict was overturned. Below is your weekly mass tort settlement news roundup for the week of June 22, 2026. Each update explains the active MDL case, what changed, and why it matters to affected families.
Pharmaceutical Mass Tort Settlement News This Week
The biggest pharmaceutical mass tort settlement news involves Depo-Provera. On June 15, 2026, Judge M. Casey Rodgers announced settlement negotiations in the Depo-Provera MDL (MDL 3140). Pfizer agreed to resolve a substantial portion of federal claims. These lawsuits allege the contraceptive shot caused meningioma brain tumors. As of June 2026, roughly 5,508 claims are consolidated. However, compensation amounts have not been finalized. The talks follow a December 2025 FDA label change warning of the meningioma link.
Meanwhile, the opioid litigation produced a notable side dispute. Giant Eagle sued its insurance broker over coverage for opioid suits. As a result, attention is shifting to who pays past settlements. In addition, the Ozempic and GLP-1 litigation (MDL 3094) keeps growing. There are now about 3,763 lawsuits covering gastroparesis and vision loss. The court held a “Science Day” on June 2, 2026, on the NAION blindness claims. No global settlement exists yet. Bellwether trials are expected in late 2026 through 2027.
For example, Sanofi recently failed to escape the Taxotere and cancer-drug eye-injury litigation. These pharmaceutical developments dominate this week’s mass tort settlement news. Affected patients should track each MDL’s bellwether schedule closely. To understand how these payouts are structured, read our guide on how mass tort settlements work.
Medical Device Lawsuit Developments
Medical device cases also featured in this week’s mass tort settlement news. A new Boston Scientific spinal cord stimulator lawsuit was filed. Plaintiffs allege the SCS device caused serious injuries and required revision surgery. This is an emerging litigation, not yet a consolidated MDL. However, early filings often signal a larger wave ahead.
Meanwhile, the hernia mesh litigation remains one of the largest device dockets. The Bard MDL alone holds roughly 24,000 pending cases. Discovery and bellwether preparation continue. In addition, Philips CPAP machine recall concerns resurfaced this week over potential cancer risk. The CPAP MDL has already produced settlement frameworks for economic loss claims. Personal injury claims are still being evaluated. As a result, device users with injuries may qualify to file new claims.
If you used any recalled device, document your implant or model details now. Affected patients may qualify for potential recovery. However, you should not assume eligibility. Always consult a licensed attorney before filing. You can also check our free eligibility quiz to see if your case fits an active MDL.
Environmental Contamination Case Updates
Environmental cases drove much of the week’s mass tort settlement news. First, the Supreme Court is expected to rule soon in Monsanto v. Durnell. Oral argument happened on April 27, 2026. The justices will decide whether federal pesticide law preempts state failure-to-warn claims. This ruling could reshape the entire Roundup litigation (MDL 2741). Over 4,000 cases remain in the federal MDL. Bayer has already paid about $11 billion across roughly 100,000 prior claims.
Meanwhile, the Paraquat MDL judge increased pressure on settlement holdouts. The court now requires holdout plaintiffs to meet with a Special Master. About 6,651 paraquat claims remain pending. These lawsuits link the weedkiller to Parkinson’s disease. In addition, a bipartisan bill was introduced to ban paraquat nationwide. Separately, a new lawsuit alleges a Dow insecticide also causes Parkinson’s. These environmental updates anchor this week’s mass tort settlement news.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
PFAS contamination news continued as well. Robeson County faces a new lawsuit over PFAS in its public water system. Florida moved to ban cancer-linked firefighting foam and require PFAS water testing. The AFFF firefighting foam litigation remains the largest environmental mass tort in U.S. history. Settlement talks target figures above $10 billion. Veterans and water-contamination victims should also review the Camp Lejeune lawsuit options. Both cases may offer potential recovery for exposure injuries.
Consumer Product Litigation News
Consumer product cases rounded out this week’s mass tort settlement news. The biggest update came from baby formula litigation. A Missouri court overturned a defense verdict and ordered a new trial in an NEC case. This reversed an earlier win for Abbott and Mead Johnson. In April 2026, a Chicago jury had awarded $70 million to four NEC families. A separate Enfamil case is set for an August jury trial. The federal NEC MDL in Illinois remains active.
Meanwhile, talc litigation stayed in focus. After Judge Lopez rejected the $8 billion bankruptcy deal, talc claims (MDL 2738) now proceed in court. Recent verdicts ranged from a $1.56 billion award to smaller wins. However, outcomes vary widely case by case. In addition, social media addiction litigation advanced. Arkansas sued Roblox and Discord over child-safety failures. Earlier, a California jury found Instagram and YouTube liable in a landmark addiction trial.
The hair relaxer litigation continues through discovery, though no settlement pressure has emerged yet. Uber’s board was also sued over driver sexual-assault failures. These consumer updates complete this week’s mass tort settlement news. For background on how these cases work, see what is a mass tort.
Key Deadlines and What to Watch in Mass Tort Settlement News
Several events deserve your attention next week. First, watch for the Supreme Court’s Durnell decision, which could land before the term ends. As a result, the entire Roundup docket may shift. Second, monitor the Depo-Provera settlement framework for compensation details. Third, track paraquat holdout meetings with the Special Master.
Meanwhile, the August Enfamil NEC trial is approaching fast. In addition, Ozempic bellwether selection continues toward late-2026 trials. Settlement values differ by state, so compare your jurisdiction using our tort reform by state tool. For the full archive of weekly updates, visit our settlement news hub. We update this mass tort settlement news digest every week. No outcome is ever certain, and you should never assume guaranteed results. If any case above affects you, contact a licensed attorney to learn whether you may qualify for potential recovery.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed June 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- New Jersey Tort Reform Guide
- North Carolina Tort Reform Guide
- Texas Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.